Shanghai ZJ Bio-Tech CoSHSE:688317 -4.33%68 Gross Margin % is 68.86% as of Mar. 2026, which is 1% below its 10-year median of 69.53. GuruFocus rates SHSE:688317 with a GF Score™ of 68/100 and a GF Value™ of ¥9.94 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Shanghai ZJ Bio-Tech Co ranks better than 71.3% on this metric.
SHSE:688317's Gross Margin % is ranked better than 71.3% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs SHSE:688317: 65.11
Shanghai ZJ Bio-Tech Co had a gross margin of 68.86% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Shanghai ZJ Bio-Tech Co was -1.60% per year.
Shanghai ZJ Bio-Tech Co (SHSE:688317) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Shanghai ZJ Bio-Tech Co had a gross margin of 68.86% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Shanghai ZJ Bio-Tech Co Gross Margin % Related Terms
Shanghai ZJ Bio-Tech Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688317 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Shanghai ZJ Bio-Tech Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai ZJ Bio-Tech Co Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai ZJ Bio-Tech Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Shanghai ZJ Bio-Tech Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Shanghai ZJ Bio-Tech Co (SHSE:688317) has a Gross Margin % of 68.86% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Shanghai ZJ Bio-Tech Co and its competitors. This is near median its historical median of 69.53. Over the past decade, Shanghai ZJ Bio-Tech Co's Gross Margin % has ranged from 51.65 to 82.51. According to the industry distribution chart, Shanghai ZJ Bio-Tech Co ranks #231 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 28.7%.
Is Shanghai ZJ Bio-Tech Co's Gross Margin % too high?
Shanghai ZJ Bio-Tech Co's current Gross Margin % of 68.86% is near median its 10-year median of 69.53. Over the past 10 years, this metric has ranged from a low of 51.65 to a high of 82.51. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Shanghai ZJ Bio-Tech Co's value of 68.86% is 32.2% above this industry median. Based on the distribution chart, Shanghai ZJ Bio-Tech Co ranks #231 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shanghai ZJ Bio-Tech Co has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai ZJ Bio-Tech Co's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai ZJ Bio-Tech Co ranks #231 out of 805 companies for Gross Margin %. This puts Shanghai ZJ Bio-Tech Co in the upper half of its industry. The industry median Gross Margin % is 52.07. Shanghai ZJ Bio-Tech Co's value of 68.86% is 32.2% above this benchmark. Historically, Shanghai ZJ Bio-Tech Co's own Gross Margin % has ranged from 51.65 to 82.51 over the past decade. While the company's 10-year median is 69.53 vs. the industry median of 52.07, Shanghai ZJ Bio-Tech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai ZJ Bio-Tech Co's current Gross Margin % of 68.86% is 32.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Shanghai ZJ Bio-Tech Co and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai ZJ Bio-Tech Co's current Gross Margin % is 68.86%, which is near median its own 10-year median of 69.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai ZJ Bio-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co (SHSE:688317) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥9.94, compared to a current price of ¥15.68 — trading 57.7% above its estimated fair value. The current Gross Margin % is 68.86%, which is near median its 10-year median of 69.53 and 32.2% above the Medical Devices & Instruments industry median of 52.07. Shanghai ZJ Bio-Tech Co's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Shanghai ZJ Bio-Tech Co (SHSE:688317), the current Gross Margin % is 68.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai ZJ Bio-Tech Co (SHSE:688317) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co stock appears to be overvalued.
The current stock price of ¥15.68 is trading 57.7% above its estimated GF Value™ of ¥9.94.
GuruFocus considers Shanghai ZJ Bio-Tech Co to be Significantly Overvalued.
Key valuation signals for SHSE:688317:
Gross Margin %: 68.86% (near median its 10-year median of 69.53)
GF Value™: ¥9.94 vs. price of ¥15.68 (57.7% above fair value)
Industry Position: 32.2% above the Medical Devices & Instruments median (#231 of 805)
No single metric tells the full story. See the SHSE:688317 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai ZJ Bio-Tech Co Ltd is engaged in research and development, production and sales of genetic diagnostic reagents and instruments and equipment. The rapid real-time fluorescent PCR diagnostic test reagents developed by the company are mainly used in clinical medicine, public health emergencies, entry-exit inspection and quarantine, food inspection, animal husbandry, aquaculture and other fields.
68GF Score
Get the complete analysis for SHSE:688317
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688317 has been successfully added to your 
